SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015649
Filing Date
2021-11-12
Accepted
2021-11-12 07:50:48
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elev-20210930x10q.htm   iXBRL 10-Q 1627713
2 EX-31.1 elev-20210930xex31d1.htm EX-31.1 10977
3 EX-31.2 elev-20210930xex31d2.htm EX-31.2 10826
4 EX-32 elev-20210930xex32.htm EX-32 7478
  Complete submission text file 0001558370-21-015649.txt   5217396

Data Files

Seq Description Document Type Size
5 EX-101.SCH elev-20210930.xsd EX-101.SCH 32963
6 EX-101.CAL elev-20210930_cal.xml EX-101.CAL 23417
7 EX-101.DEF elev-20210930_def.xml EX-101.DEF 140405
8 EX-101.LAB elev-20210930_lab.xml EX-101.LAB 328914
9 EX-101.PRE elev-20210930_pre.xml EX-101.PRE 259983
10 EXTRACTED XBRL INSTANCE DOCUMENT elev-20210930x10q_htm.xml XML 709456
Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Filer) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40523 | Film No.: 211399652
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences